Inmed Pharmaceuticals Inc. · NASDAQ:INM

Vivo Opportunity Cayman Fund, L.P. bought 20,546 Inmed Pharmaceuticals Inc. shares (Form 4)

Traded Jul 14 to Jul 16, 2026 · Filed Jul 16, 2026

From Jul 14 to Jul 16, 2026, Vivo Opportunity Cayman Fund, L.P. (10% owner) bought 20,546 Inmed Pharmaceuticals Inc. shares at US$1.55 for US$31,846, leaving 75,019 shares. Filed Jul 16, 2026 (Form 4).

Bought
20,546 shares
Price
US$1.55
Value
US$31,846
Holding after
75,019 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 14, 2026Common SharesBuy4,882US$1.55729,277Indirect
Jul 14, 2026Common SharesBuy493US$1.5573,628Indirect
Jul 15, 2026Common SharesBuy13,761US$1.55743,038Indirect
Jul 15, 2026Common SharesBuy1,389US$1.5575,017Indirect
Jul 16, 2026Common SharesBuy19US$1.55743,057Indirect
Jul 16, 2026Common SharesBuy2US$1.5575,019Indirect

Source

View original at SEC

Related